{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:29:05Z","timestamp":1787009345993,"version":"build-2736575974"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T00:00:00Z","timestamp":1628640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,1,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Hidradenitis suppurativa (HS) is a chronic inflammatory disease characterised by pain, inflamed nodules, abscess, sinus tract, and fistula. HS is more common in patients with axial spondyloarthritis and Familial Mediterranean Fever (FMF) compared to the normal population. Mediterranean fever gene mutations are thought to be responsible for the relationship between these three diseases. Case reports of secukinumab treatment in HS have been reported. In this article, a case of successful treatment of HS with secukinumab in a patient with ankylosing spondylitis and FMF is presented.<\/jats:p>","DOI":"10.1093\/mrcr\/rxab008","type":"journal-article","created":{"date-parts":[[2021,9,7]],"date-time":"2021-09-07T10:31:32Z","timestamp":1631010692000},"page":"19-21","source":"Crossref","is-referenced-by-count":5,"title":["Successful treatment of hidradenitis suppurativa with secukinumab in a patient with ankylosing spondylitis and Familial Mediterranean Fever"],"prefix":"10.1093","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0273-6268","authenticated-orcid":false,"given":"Ayse","family":"Unal Enginar","sequence":"first","affiliation":[{"name":"Rheumatology, Ordu State Hospital, Ordu, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Gundogdu","sequence":"additional","affiliation":[{"name":"Dermatology and Venereology, Ordu State Hospital, Ordu, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,8,11]]},"reference":[{"key":"2022011123195353900_R1","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1001\/jama.2017.16691","article-title":"Hidradenitis suppurativa: advances in diagnosis and treatment","volume":"318","author":"Saunte","year":"2017","journal-title":"JAMA"},{"key":"2022011123195353900_R2","doi-asserted-by":"crossref","DOI":"10.1038\/s41572-020-0149-1","article-title":"Hidradenitis suppurativa","volume":"6","author":"Sabat","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"2022011123195353900_R3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031810","article-title":"Increased prevalence of metabolic syndrome in patients with acne inversa","volume":"7","author":"Sabat","year":"2012","journal-title":"PLoS One"},{"key":"2022011123195353900_R4","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.4049\/jimmunol.0903907","article-title":"Deficiency of IL-22 contributes to a chronic inflammatory disease: pathogenetic mechanisms in acne inversa","volume":"186","author":"Wolk","year":"2011","journal-title":"J Immunol"},{"key":"2022011123195353900_R5","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.jid.2016.11.040","article-title":"Prevalence and risk of inflammatory bowel disease in patients with hidradenitis suppurativa","volume":"137","author":"Egeberg","year":"2017","journal-title":"J Invest Dermatol"},{"key":"2022011123195353900_R6","first-page":"1784","article-title":"High prevalence of hidradenitis suppurativa symptoms in axial spondyloarthritis patients: a possible new extra-articular manifestation","volume":"32","author":"Rondags","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2022011123195353900_R7","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.jbspin.2017.09.005","article-title":"Association between hidradenitis suppurativa and spondyloarthritis","volume":"85","author":"Fauconier","year":"2018","journal-title":"Joint Bone Spine"},{"key":"2022011123195353900_R8","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.13645","article-title":"Are there any clinical differences between ankylosing spondylitis patients and familial Mediterranean fever patients with ankylosing spondylitis?","volume":"75","author":"Yazici","year":"2021","journal-title":"Int J Clin Pract"},{"key":"2022011123195353900_R9","doi-asserted-by":"crossref","first-page":"148","DOI":"10.2174\/1871530317666171003155517","article-title":"Ankylosing spondylitis among familial Mediterranean fever patients","volume":"18","author":"Merashli","year":"2018","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"2022011123195353900_R10","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jbspin.2016.02.021","article-title":"Association of hidradenitis suppurativa and familial Mediterranean fever: a case series of 6 patients","volume":"84","author":"Abbara","year":"2017","journal-title":"Joint Bone Spine"},{"key":"2022011123195353900_R11","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1111\/bjd.17466","article-title":"Association of pyrin mutations and autoinflammation with complex phenotype hidradenitis sup-purativa: a case-control study","volume":"180","author":"Vural","year":"2018","journal-title":"Br J Dermatol"},{"key":"2022011123195353900_R12","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1159\/000506074","article-title":"Paradoxical hidradenitis suppurativa in patients receiving TNF-\u03b1 inhibitors: case series, systematic review, and case meta-analysis","volume":"236","author":"Salvador-Rodriguez","year":"2020","journal-title":"Dermatology"},{"key":"2022011123195353900_R13","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jdcr.2018.12.002","article-title":"Secukinumab and hidradenitis suppurativa: friends or foes?","volume":"5","author":"Marasca","year":"2019","journal-title":"JAAD Case Rep"},{"key":"2022011123195353900_R14","doi-asserted-by":"crossref","DOI":"10.1111\/dth.13845","article-title":"Severe hidradenitis suppurativa successfully treated with secukinumab","volume":"33","author":"G\u0142owaczewska","year":"2020","journal-title":"Dermatol Ther"},{"key":"2022011123195353900_R15","doi-asserted-by":"crossref","DOI":"10.1111\/dth.13150","article-title":"Secukinumab-induced paradoxical hidradenitis suppurativa","volume":"33","author":"Navarro-Trivi\u00f1o","year":"2020","journal-title":"Dermatol Ther"}],"container-title":["Modern Rheumatology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/mrcr\/advance-article-pdf\/doi\/10.1093\/mrcr\/rxab008\/41745706\/rxab008.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mrcr\/article-pdf\/6\/1\/19\/42106845\/rxab008.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mrcr\/article-pdf\/6\/1\/19\/42106845\/rxab008.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T21:46:58Z","timestamp":1642542418000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mrcr\/article\/6\/1\/19-21\/6348291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,11]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,8,11]]},"published-print":{"date-parts":[[2022,1,7]]}},"URL":"https:\/\/doi.org\/10.1093\/mrcr\/rxab008","relation":{},"ISSN":["2472-5625"],"issn-type":[{"value":"2472-5625","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,1,1]]},"published":{"date-parts":[[2021,8,11]]}}}